Human papillomavirus and cervical cancer behavioral surveillance in the US

Jasmin A. Tiro, Mona Saraiya, Nidhi Jain, Nicole Liddon, Vilma Cokkinides, Sue Min Lai, Nancy Breen, Louise Wideroff

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.

Original languageEnglish (US)
Pages (from-to)3013-3030
Number of pages18
JournalCancer
Volume113
Issue number10 SUPPL.
DOIs
StatePublished - Nov 15 2008

Fingerprint

Uterine Cervical Neoplasms
Technology
Behavioral Research
Papanicolaou Test
Mortality
Health Services Needs and Demand
Incidence
Information Systems
Reproducibility of Results
Sexual Behavior
Self Report
Population
Neoplasms
Vaccination
Behavior Rating Scale

Keywords

  • Behavioral surveillance
  • Cervical cancer
  • Human papillomavirus
  • Papanicolaou test use

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tiro, J. A., Saraiya, M., Jain, N., Liddon, N., Cokkinides, V., Lai, S. M., ... Wideroff, L. (2008). Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer, 113(10 SUPPL.), 3013-3030. https://doi.org/10.1002/cncr.23760

Human papillomavirus and cervical cancer behavioral surveillance in the US. / Tiro, Jasmin A.; Saraiya, Mona; Jain, Nidhi; Liddon, Nicole; Cokkinides, Vilma; Lai, Sue Min; Breen, Nancy; Wideroff, Louise.

In: Cancer, Vol. 113, No. 10 SUPPL., 15.11.2008, p. 3013-3030.

Research output: Contribution to journalArticle

Tiro, JA, Saraiya, M, Jain, N, Liddon, N, Cokkinides, V, Lai, SM, Breen, N & Wideroff, L 2008, 'Human papillomavirus and cervical cancer behavioral surveillance in the US', Cancer, vol. 113, no. 10 SUPPL., pp. 3013-3030. https://doi.org/10.1002/cncr.23760
Tiro JA, Saraiya M, Jain N, Liddon N, Cokkinides V, Lai SM et al. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer. 2008 Nov 15;113(10 SUPPL.):3013-3030. https://doi.org/10.1002/cncr.23760
Tiro, Jasmin A. ; Saraiya, Mona ; Jain, Nidhi ; Liddon, Nicole ; Cokkinides, Vilma ; Lai, Sue Min ; Breen, Nancy ; Wideroff, Louise. / Human papillomavirus and cervical cancer behavioral surveillance in the US. In: Cancer. 2008 ; Vol. 113, No. 10 SUPPL. pp. 3013-3030.
@article{d041a6a6a900471c9ecc9128579fef53,
title = "Human papillomavirus and cervical cancer behavioral surveillance in the US",
abstract = "In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.",
keywords = "Behavioral surveillance, Cervical cancer, Human papillomavirus, Papanicolaou test use",
author = "Tiro, {Jasmin A.} and Mona Saraiya and Nidhi Jain and Nicole Liddon and Vilma Cokkinides and Lai, {Sue Min} and Nancy Breen and Louise Wideroff",
year = "2008",
month = "11",
day = "15",
doi = "10.1002/cncr.23760",
language = "English (US)",
volume = "113",
pages = "3013--3030",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "10 SUPPL.",

}

TY - JOUR

T1 - Human papillomavirus and cervical cancer behavioral surveillance in the US

AU - Tiro, Jasmin A.

AU - Saraiya, Mona

AU - Jain, Nidhi

AU - Liddon, Nicole

AU - Cokkinides, Vilma

AU - Lai, Sue Min

AU - Breen, Nancy

AU - Wideroff, Louise

PY - 2008/11/15

Y1 - 2008/11/15

N2 - In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.

AB - In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.

KW - Behavioral surveillance

KW - Cervical cancer

KW - Human papillomavirus

KW - Papanicolaou test use

UR - http://www.scopus.com/inward/record.url?scp=56449091027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449091027&partnerID=8YFLogxK

U2 - 10.1002/cncr.23760

DO - 10.1002/cncr.23760

M3 - Article

C2 - 18980284

AN - SCOPUS:56449091027

VL - 113

SP - 3013

EP - 3030

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10 SUPPL.

ER -